(19)
(11) EP 3 595 706 A1

(12)

(43) Date of publication:
22.01.2020 Bulletin 2020/04

(21) Application number: 18716423.1

(22) Date of filing: 16.03.2018
(51) International Patent Classification (IPC): 
A61K 39/00(2006.01)
(86) International application number:
PCT/US2018/022998
(87) International publication number:
WO 2018/170475 (20.09.2018 Gazette 2018/38)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA ME
Designated Validation States:
KH MA MD TN

(30) Priority: 17.03.2017 US 201762473282 P
12.02.2018 US 201862629663 P

(71) Applicant: Fred Hutchinson Cancer Research Center
Seattle, WA 98109 (US)

(72) Inventors:
  • ODA, Shannon, K.
    Lake Forest Park Washington 98155 (US)
  • GREENBERG, Philip, D.
    Mercer Island Washington 98040 (US)
  • SCHMITT, Thomas, M.
    Seattle Washington 98119 (US)

(74) Representative: Hoffmann Eitle 
Patent- und Rechtsanwälte PartmbB Arabellastraße 30
81925 München
81925 München (DE)

   


(54) IMMUNOMODULATORY FUSION PROTEINS AND USES THEREOF